36th Annual International Narcotics Research Conference
第 36 届国际麻醉品研究年度会议
基本信息
- 批准号:7005344
- 负责人:
- 金额:$ 6.5万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2005
- 资助国家:美国
- 起止时间:2005-07-10 至 2005-07-15
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DESCRIPTION (provided by applicant):
Support is requested for the 36th annual meeting of the International Narcotics Research Conference (INRC) to be held in Annapolis, Maryland from July 10-15, 2005. INRC has for many years been the most prestigious international meeting for the dissemination and exchange of information about biomedical research on opiate drugs and the endogenous opioid system. The topics range from molecular to behavioral and clinical studies. While the main topic is still opiate drugs and abuse, there is increasing discussion of other abused drugs, such as marijuana, cocaine, amphetamines, and alcohol, since extensively interactions between these drugs and the endogenous opioid system has been documented. Support is requested primarily for partial travel support to enable young scientists, i.e. graduate students, postdoctoral fellows, and junior faculty, to participate in the Conference. A small portion of funds will support distinguished plenary speakers from other disciplines, relevant to research on addictive drugs, who will describe strategies, concepts or techniques likely to be useful to an INRC audience. Invited symposium speakers, not normally INRC participants, will receive partial support. Funds requested for administrative and meeting expenses represent about 15% of the total. This year INRC has five confirmed plenary speakers on various topics, including Drs. N. Volkow, Director of NIDA, S. Snyder, Johns Hopkins Univ., T Robbins, UK, R Huganir, Johns Hopkins Univ., and M Caron, Duke Univ. Dr. Mary Jeanne Kreek was elected the Founders' Lecturer for the 2005 Meeting. Eight symposia will cover a wide range of topics described in the application, including human genetics of drug abuse, prescription versus non-prescription drug abuse, and new advances in pain research. A number of relevant contributed papers will be chosen for oral presentation at each symposium. There will be three poster sessions, at which there is always much exchange and discussion. There will be a workshop on NIDA updates and grant writing. The location of this meeting will allow investigators the opportunity to interact with NIDA and NIH staff. For participants from many countries, this international meeting is their only chance to meet and exchange ideas. We feel that participation by many pre- and postdoctoral trainees has resulted and is likely to continue to result in recruiting promising scientists to a career of drug abuse research.
描述(由申请人提供):
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
JEAN M BIDLACK其他文献
JEAN M BIDLACK的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('JEAN M BIDLACK', 18)}}的其他基金
G alpha Z subunit as a potential therapeutic target to modulate mu opioid receptor pharmacology
G α Z 亚基作为调节 mu 阿片受体药理学的潜在治疗靶点
- 批准号:
10580415 - 财政年份:2022
- 资助金额:
$ 6.5万 - 项目类别:
38th Annual International Narcotics Research Conference
第 38 届国际麻醉品研究年度会议
- 批准号:
7334676 - 财政年份:2007
- 资助金额:
$ 6.5万 - 项目类别:
37th Annual International Narcotics Research Conference
第 37 届国际麻醉品研究年度会议
- 批准号:
7167690 - 财政年份:2006
- 资助金额:
$ 6.5万 - 项目类别:
Opioid Binding to U51: A Human herpes Virus Protein
阿片类药物与 U51 结合:人类疱疹病毒蛋白
- 批准号:
6447741 - 财政年份:2001
- 资助金额:
$ 6.5万 - 项目类别:
Opioid Binding to U51: A Human herpes Virus Protein
阿片类药物与 U51 结合:人类疱疹病毒蛋白
- 批准号:
6523577 - 财政年份:2001
- 资助金额:
$ 6.5万 - 项目类别:
相似海外基金
Effects of HIV-1 Tat protein and methamphetamine on VMAT2-mediated dopamine transmission in the context of neuroHIV and drug abuse
HIV-1 Tat 蛋白和甲基苯丙胺对神经 HIV 和药物滥用背景下 VMAT2 介导的多巴胺传递的影响
- 批准号:
10698618 - 财政年份:2023
- 资助金额:
$ 6.5万 - 项目类别:
Genetics of novelty seeking and propensity for drug abuse in outbred rats
近交系大鼠寻求新奇事物的遗传学和药物滥用倾向
- 批准号:
10669951 - 财政年份:2023
- 资助金额:
$ 6.5万 - 项目类别:
The ANTIDOTE Institute- Advancing New Toxicology Investigators in Drug abuse and Original Translational research Efforts
ANTIDOTE Institute - 推动新毒理学研究人员在药物滥用和原创转化研究工作中的发展
- 批准号:
10681927 - 财政年份:2023
- 资助金额:
$ 6.5万 - 项目类别:
The neuropharmacology of brain activation during stages of drug abuse
药物滥用阶段大脑激活的神经药理学
- 批准号:
10681576 - 财政年份:2023
- 资助金额:
$ 6.5万 - 项目类别:
SCC-PG: Securing Underserved Communities from Drug Abuse with Drone-Based Smart Medication Delivery
SCC-PG:通过基于无人机的智能药物输送,确保服务不足的社区免受药物滥用
- 批准号:
2231710 - 财政年份:2023
- 资助金额:
$ 6.5万 - 项目类别:
Standard Grant
Analysis of modulation of the metabotropic glutamate receptor type 5 in a novel heritable model of drug abuse vulnerability
药物滥用易感性新型遗传模型中 5 型代谢型谷氨酸受体的调节分析
- 批准号:
10754809 - 财政年份:2023
- 资助金额:
$ 6.5万 - 项目类别:
Using Integrative Data Analysis to Examine the Impact of Psychosocial Treatments for Black Cocaine Users Enrolled in the NIDA Drug Abuse Treatment Clinical Trials Network (CTN)
使用综合数据分析来检查心理社会治疗对参加 NIDA 药物滥用治疗临床试验网络 (CTN) 的黑色可卡因使用者的影响
- 批准号:
10683020 - 财政年份:2022
- 资助金额:
$ 6.5万 - 项目类别:
Interdisciplinary Graduate Training through Research in Artificial Intelligence and Secure Networked Sensing to Mitigate the Crisis of Alcohol and Drug Abuse
通过人工智能和安全网络传感研究进行跨学科研究生培训,以缓解酒精和药物滥用危机
- 批准号:
2152057 - 财政年份:2022
- 资助金额:
$ 6.5万 - 项目类别:
Standard Grant
Great Lakes Node of the Drug Abuse Clinical Trials Network
药物滥用临床试验网络五大湖节点
- 批准号:
10662573 - 财政年份:2022
- 资助金额:
$ 6.5万 - 项目类别:
Great Lakes Node of the Drug Abuse Clinical Trials Network
药物滥用临床试验网络五大湖节点
- 批准号:
10583828 - 财政年份:2022
- 资助金额:
$ 6.5万 - 项目类别: